{
    "title": "Monthly 100,000 IU of vitamin D decreased respiratory infection but increased falls",
    "slug": "monthly-100000-iu-of-vitamin-d-decreased-respiratory-infection-but-increased-falls",
    "aliases": [
        "/Monthly+100000+IU+of+vitamin+D+decreased+respiratory+infection+but+increased+falls+\u2013+Nov+2016",
        "/8052"
    ],
    "tiki_page_id": 8052,
    "date": "2016-11-30",
    "categories": [
        "Breathing",
        "Intervention",
        "Falls and Fractures"
    ],
    "tags": [
        "Breathing",
        "Falls and Fractures",
        "Intervention",
        "blood levels",
        "bone",
        "breathing",
        "dosage",
        "falls fractures",
        "high dose",
        "respiratory",
        "therapeutic intervention",
        "vitamin d",
        "vitamin d blood test"
    ]
}


<h4 class="showhide_heading" id="High-Dose_Monthly_Vitamin_D_for_Prevention_of_Acute_Respiratory_Infection_in_Older_Long-Term_Care_Residents:_A_Randomized_Clinical_Trial">

High-Dose Monthly Vitamin D for Prevention of Acute Respiratory Infection in Older Long-Term Care Residents: A Randomized Clinical Trial</h4>

<p>

Journal of the American Geriatrics Society, First published: 16 November 2016, DOI: 10.1111/jgs.14679<br />

Adit A. Ginde MD, MPH, Patrick Blatchford PhD, Keith Breese MA, Lida Zarrabi MPH,<br />

Sunny A. Linnebur PharmD, Jeffrey I. Wallace MD, MPH, Robert S. Schwartz MD</p>

<div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">

RCT with 100,000 IU monthly to 107 seniors in long term care facility

Trial lasted for 12 months

Decreased acute respiratory infection by 40%

Increased risk of falls by 2.3 X

No difference in nunber of fractures between the groups

 **VitaminDWiki suspects** 

Those getting high dose vitamin D felt better ==> moved more ==>fell more

 **A RCT does not permit warning high dose participants to beware of moving more when feeling better** 

 **Note** 

th high dose group only achieved a median of 32 ng/mL

That is, half had more than 32 ng and half had less than 32 ng

Need much more Vitamin D (200,000 montly?) to get most of participants above 32 ng

</div>

<p>

<strong><a class="wiki external" href="http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgs.14679/full" rel="external nofollow" target="_blank">Publisher rents PDF for $6</a></strong></p>

<p>

Objectives: To determine the efficacy and safety of high-dose vitamin D supplementation for prevention of acute respiratory infection (ARI) in older long-term care residents.</p>

<p>

Design: Randomized controlled trial investigating high-dose vs standard-dose vitamin D from 2010 to 2014.</p>

<p>

Setting: Colorado long-term care facilities.</p>

<p>

Participants: Long-term care residents aged 60 and older (n = 107).</p>

<p>

Intervention: The high-dose group received monthly supplement of vitamin D3 100,000 IU, the standard-dose group received a monthly placebo (for participants taking 400–1,000 IU/d as part of usual care) or a monthly supplement of 12,000 IU of vitamin D3 (for participants taking &lt;400 IU/d as part of usual care).</p>

<p>

Measurements: The primary outcome was incidence of ARI during the <strong>12-month intervention</strong>.<br />

Secondary outcomes were falls and fractures, 25-hydroxyvitamin D levels, hypercalcemia, and kidney stones.</p>

<p>

Results: Participants (55 high dose, 52 standard dose) were randomized and included in the final analysis.<br />

The high-dose group had 0.67 ARIs per person-year and the standard-dose group had 1.11 (incidence rate ratio (IRR) = <strong>0.60</strong>, 95% confidence interval (CI) = 0.38–0.94, P = .02).<br />

Falls were more common in the high-dose group (1.47 per person-year vs 0.63 in standard-dose group; IRR = <strong>2.33</strong>, 95% CI = 1.49–3.63, P &lt; .001).<br />

Fractures were uncommon and similar in both groups (high dose 0.10 vs standard dose 0.19 per person-year; P = .31).<br />

Mean trough 25-hydroxyvitamin D levels during the trial were 32. ng/mL in the high-dose group and 25.1 ng/mL in the standard-dose group.<br />

There was no hypercalcemia or kidney stones in either group.</p>

<p>

Conclusion: Monthly high-dose vitamin D3 supplementation reduced the incidence of ARI in older long-term care residents but was associated with a higher rate of falls without an increase in fractures.</p>

<p>

Table from study</p>

<table style="width:662px;"><tbody><tr><td style="width:350px;">

<p>

System Organ Class </p>

</td>

<td style="width:90px;">

<p>

High Dose</p>

</td>

<td style="width:120px;">

<p>

Standard Dose</p>

</td>

</tr><tr><td style="width:350px;">

<p>

</p>

</td>

<td colspan="2" style="width:210px;">

<p>

n (%)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

<strong>Blood and lymphatic system disorders</strong></p>

</td>

<td style="width:90px;">

<p>

7 (13)</p>

</td>

<td style="width:120px;">

<p>

4 (8)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

<strong>Cardiac disorders</strong></p>

</td>

<td style="width:90px;">

<p>

15 (27)</p>

</td>

<td style="width:120px;">

<p>

9 (17)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Dermal and epidermal conditions</p>

</td>

<td style="width:90px;">

<p>

0 (0)</p>

</td>

<td style="width:120px;">

<p>

0 (0)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

<strong>Ear and labyrinth disorders (cause falls?)</strong></p>

</td>

<td style="width:90px;">

<p>

6 (11)</p>

</td>

<td style="width:120px;">

<p>

1 (2)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

<strong>Endocrine disorders</strong></p>

</td>

<td style="width:90px;">

<p>

3 (5)</p>

</td>

<td style="width:120px;">

<p>

0 (0)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Eye disorders (fewer)</p>

</td>

<td style="width:90px;">

<p>

5 (9)</p>

</td>

<td style="width:120px;">

<p>

7 (13)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Gastrointestinal disorders <span style="font-size:.75em;"> (fewer)</span></p>

</td>

<td style="width:90px;">

<p>

22 (40)</p>

</td>

<td style="width:120px;">

<p>

27 (52)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

General disorders and administration site conditions</p>

</td>

<td style="width:90px;">

<p>

39 (71)</p>

</td>

<td style="width:120px;">

<p>

28 (54)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Hepatobiliary disorders</p>

</td>

<td style="width:90px;">

<p>

1 (2)</p>

</td>

<td style="width:120px;">

<p>

1 (2)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Immune system disorders</p>

</td>

<td style="width:90px;">

<p>

9 (16)</p>

</td>

<td style="width:120px;">

<p>

7 (13)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Infections and infestations</p>

</td>

<td style="width:90px;">

<p>

21 (38)</p>

</td>

<td style="width:120px;">

<p>

21 (40)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Injury, poisoning, and procedural complications</p>

</td>

<td style="width:90px;">

<p>

29 (53)</p>

</td>

<td style="width:120px;">

<p>

30 (58)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Investigations</p>

</td>

<td style="width:90px;">

<p>

16 (29)</p>

</td>

<td style="width:120px;">

<p>

12 (23)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Metabolic, nutritional, and blood gas investigations</p>

</td>

<td style="width:90px;">

<p>

18 (33)</p>

</td>

<td style="width:120px;">

<p>

15 (29)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Musculoskeletal and connective tissue disorders</p>

</td>

<td style="width:90px;">

<p>

17 (31)</p>

</td>

<td style="width:120px;">

<p>

16 (31)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Neoplasms benign, malignant, and unspecified</p>

</td>

<td style="width:90px;">

<p>

1 (2)</p>

</td>

<td style="width:120px;">

<p>

1 (2)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Nervous system disorders</p>

</td>

<td style="width:90px;">

<p>

10 (18)</p>

</td>

<td style="width:120px;">

<p>

10 (19)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Neuromuscular disorders</p>

</td>

<td style="width:90px;">

<p>

1 (2)</p>

</td>

<td style="width:120px;">

<p>

0 (0)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Ocular infections, irritations, and inflammations</p>

</td>

<td style="width:90px;">

<p>

0 (0)</p>

</td>

<td style="width:120px;">

<p>

0 (0)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Psychiatric disorders</p>

</td>

<td style="width:90px;">

<p>

30 (55)</p>

</td>

<td style="width:120px;">

<p>

19 (37)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Renal and urinary disorders</p>

</td>

<td style="width:90px;">

<p>

13 (24)</p>

</td>

<td style="width:120px;">

<p>

10 (19)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Reproductive systems and breast disorders</p>

</td>

<td style="width:90px;">

<p>

6 (11)</p>

</td>

<td style="width:120px;">

<p>

2 (4)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Respiratory, thoracic, and mediastinal disorders</p>

</td>

<td style="width:90px;">

<p>

24 (44)</p>

</td>

<td style="width:120px;">

<p>

30 (58)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Skin and subcutaneous tissue disorders</p>

</td>

<td style="width:90px;">

<p>

23 (42)</p>

</td>

<td style="width:120px;">

<p>

22 (42)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Social circumstances</p>

</td>

<td style="width:90px;">

<p>

1 (2)</p>

</td>

<td style="width:120px;">

<p>

0 (0)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Surgical and medical procedures</p>

</td>

<td style="width:90px;">

<p>

14 (25)</p>

</td>

<td style="width:120px;">

<p>

6 (12)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Vascular disorders</p>

</td>

<td style="width:90px;">

<p>

0 (0)</p>

</td>

<td style="width:120px;">

<p>

0 (0)</p>

</td>

</tr><tr><td style="width:350px;">

<p>

Total with ≥1 adverse events</p>

</td>

<td style="width:90px;">

<p>

53 (96)</p>

</td>

<td style="width:120px;">

<p>

49 (94)</p>

</td>

</tr></tbody></table><p>

</p>